Long-term acute care hospitals provide better outcomes and more cost-effective care when treating critically ill and medically complex patients.
A new study published in Medical Care found that long-term acute care hospitals (LTCH) provide better outcomes and more cost-effective care when treating critically ill and medically complex patients.
Researchers from the National Association of Long Term Hospitals (NALTH) examined non-ventilator patients with multiple organ failures who spent 3 days or more in an LTCH intensive care unit. Of this population, the authors of the study discovered that the patients had similar or lower Medicare costs as well as lower mortality rates.
By comparing LTCH patients to those in other skilled nursing facilities and inpatient rehabilitation facilities, researchers found that Medicare costs differed specifically for patients at an LTCH with circulatory, digestive and musculoskeletal and connective tissue conditions. These patients had lower costs ranging from $13,806 to $20,809.
"As our population ages and the incidence of chronic disease increases, critically ill and medically complex patients will represent a growing segment of the Medicare population," Lane Koenig, PhD, director of Policy and Research for NALTH, and the study's lead author, said in a statement. "Because care for these patients requires a significant amount of healthcare resources, it's important to identify cost-effective treatment approaches."
The study identified 5 diagnostic categories using Medicare data from 2009-2010, which included respiratory, circulatory, digestive, musculoskeletal, and connective tissues, and further examined high severity cases. Researchers reported that LTCH care was the superior treatment option for 7 of the 10 research groups, while another group demonstrated reduced mortality but at a higher cost.
"LTCHs must be part of the conversation as payers seek ways to improve outcomes and reduce treatment costs for patients with significant illnesses," Cheryl Burzynski, NALTH president, added.
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen